Celldex Therapeutics buy Wells Fargo & Company
Start price
29.07.26
/
50%
€32.68
Target price
29.07.27
€63.18
Performance (%)
1.81%
Price
31.07.26
€32.95
Summary
This prediction is currently active. With a performance of 1.81%, the BUY prediction by Wells_Fargo___Compan for Celldex Therapeutics is trending in the right direction. This prediction currently runs until 29.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 1.81% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Wells Fargo & Company from $48.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€42.08
22.07.27
22.07.27
9.48%
31.07.26
31.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.84
13.05.26
13.05.26
€46.01
13.05.27
13.05.27
19.83%
31.07.26
31.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
81.30%
31.07.26
31.07.26